Unknown

Dataset Information

0

H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells.


ABSTRACT: The most recently characterized H4 histamine receptor (H4R) is expressed preferentially in the bone marrow, raising the question of its role during hematopoiesis. Here we show that both murine and human progenitor cell populations express this receptor subtype on transcriptional and protein levels and respond to its agonists by reduced growth factor-induced cell cycle progression that leads to decreased myeloid, erythroid and lymphoid colony formation. H4R activation prevents the induction of cell cycle genes through a cAMP/PKA-dependent pathway that is not associated with apoptosis. It is mediated specifically through H4R signaling since gene silencing or treatment with selective antagonists restores normal cell cycle progression. The arrest of growth factor-induced G1/S transition protects murine and human progenitor cells from the toxicity of the cell cycle-dependent anticancer drug Ara-C in vitro and reduces aplasia in a murine model of chemotherapy. This first evidence for functional H4R expression in hematopoietic progenitors opens new therapeutic perspectives for alleviating hematotoxic side effects of antineoplastic drugs.

SUBMITTER: Petit-Bertron AF 

PROVIDER: S-EPMC2720606 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells.

Petit-Bertron Anne-France AF   Machavoine François F   Defresne Marie Paule MP   Gillard Michel M   Chatelain Pierre P   Mistry Prakash P   Schneider Elke E   Dy Michel M  

PloS one 20090807 8


The most recently characterized H4 histamine receptor (H4R) is expressed preferentially in the bone marrow, raising the question of its role during hematopoiesis. Here we show that both murine and human progenitor cell populations express this receptor subtype on transcriptional and protein levels and respond to its agonists by reduced growth factor-induced cell cycle progression that leads to decreased myeloid, erythroid and lymphoid colony formation. H4R activation prevents the induction of ce  ...[more]

Similar Datasets

| S-EPMC3173574 | biostudies-literature
| S-EPMC6594066 | biostudies-literature
| S-EPMC524079 | biostudies-literature
| S-EPMC2630102 | biostudies-literature
| S-EPMC4155270 | biostudies-literature
| S-EPMC8508626 | biostudies-literature
| S-EPMC4542300 | biostudies-literature
| S-EPMC8394291 | biostudies-literature
| S-EPMC4379874 | biostudies-literature
| S-EPMC2697796 | biostudies-literature